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Covid-19 Pandemic
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The outbreak of the Coronavirus disease 2019 (COVID-19) 
occurred in Wuhan City, in the province of Hubei, China, in 
early December 2019. Rapidly spreading around the world 
COVID-19 became a serious disease of international concern, 
and on March 11th 2020 COVID-19 was declared a pandemic 
by the World Health Organization. Different control and pre-
vention strategies were implemented worldwide to prevent a 
rapid transmission. 
Health care settings are known locations of significance as 
sources of viral transmissions (1). In Italy, hospitals have 
been places with very high risk of COVID-19 transmissions. 
In Denmark, one third of all people infected with COVID-19 
in the entire country were healthcare workers. Therefore, 
different strategies regarding regulations in health care set-
tings have been suggested, and continuously changed, based 
on availability of testing and personal protective equipment. 
In the field of dermatology most visits are outpatients and 
non-emergent. Looking at flow, dermatology clinics are high 
volume clinics with exposure to many individuals. The latter 
combined with our knowledge of asymptomatic carriers who 
can shed viral particles weeks before (or without) symptoms 
force us to develop precautional strategies.
In a recently published letter to the Editor, Villani et al. (2) sug-
gested 4 measures in dermatological practices. Amongst these 
was the suggestion to cancel all elective outpatient visits and 
replace them with teledermatological visits. The teledermato-
logical visit consists of store-and-forward pictures, live video 
consultations, or a combination of both. These measures are 
now also supported by the new guidelines from Centers for 
Disease Control and Prevention and the American Academy 
of Dermatology (3). 
The COVID-19 pandemic has caused an increase in the use 
of telemedicine in ways we have never seen before. The 
COVID-19 pandemic forced us to drop regular face-to-face 
consultations from one day to the next, and replace them 
with telephone consultations and telemedicine (4). Earlier, 
there was often a resistance to the use of telemedicine, but the 
COVID-19 pandemic has really accelerated the use of it (5).
The increased utilization of telemedicine has provided more 
knowledge about the benefits and obstacles of the use of tele-
medicine compared with face-to-face interactions. Research 
has shown that telemedicine consultations start less structured 
and organized than face-to-face consultations. The lack of 
structure in the beginning of the telemedicine consultation is 
due to disturbing factors such as establishing the video con-
nection, adjusting volume and adjusting computer screens. 
However, already after a very short time the structures of 
telemedicine and face-to-face consultations get similar, and 
patients are in general very satisfied with telemedicine consul-
tations. Teledermatology is now considered a dermatological 
subspecialty that combines communication technologies with 
information to prevent, diagnose, treat, monitor, research and 
educate over a distance. Last year the Nordic Forum for Derma-
to-venereology launched a thema tic issue on teledermatology, 
including reports on the use of teledermatology in the Nordic 
countries and Greenland (6). The thematic issue reported on 
current practices in our countries, and the use of different 
types of teledermatology applications. These different types 
of teledermatology models include direct communication 
between the patient and the dermatologist, communication 
between the general practitioner/nurse and the dermatologist 
or communication as second opinion amongst dermatologists. 
Teledermatology can be provided through different modalities. 
Real-time video consultation between seeker and provider 
gives the possibility to further explore the medical history 
and ask clarifying questions. This modality has the drawbacks 
of being more time-consuming and being dependent on the 
quality of the connection (the Internet speed). The modality 
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we continue to use teledermatological modalities to a high 
degree, also when the COVID-19 pandemic fades away (5). 
Furthermore, continuous development of mobile phone-based 
applications and modalities is necessary to provide the best 
way of telemedical working tools (12). 
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of the asynchronous store-and-forward refers to the use of sent 
clinical or dermoscopic images. The quality of store-and-for-
ward images is often better, but the limitation of this modality 
is the lack of possibility of asking clarifying questions before 
a possible second consultation.
Combinations of both modalities are also possible based on 
what technical communication equipment is available. Avail-
ability of both options are somehow a necessity for providing 
safe and reliable care covering the entire spectrum of derma-
tological diseases. The use of teledermatology is widespread 
across the world and several studies have shown that this is 
a good alternative to regular consultations with a dermatolo-
gist, mostly because of its emphasis on visual diagnosis (7–9). 
Teledermatology has proved to provide accurate diagnosis 
and it reduces the time for treatment generating high patient 
satisfaction. The possible savings in health care expenses are 
substantial, as are possible time savings through the reduced 
need of travels. Teledermatology also provides better access to 
specialist expertise irrespective of geography. The limitations 
include both the technical aspects with quality of the con-
nection and of the images provided, and the aspect of lost/
missing information which is more easily achieved through 
a face-to-face consultation. 
Until the COVID-19 pandemic, teledermatology was often 
used when there was a large geographical distance between 
the patient and the dermatologist, for example to provide 
specialist dermatological care in remote areas (10, 11). 
COVID-19 has changed this and telemedicine is now also used 
for patients living in the same city or area as the dermatologist, 
in order to reduce the risk of COVID-19 transmission. During 
the COVID-19 pandemic new boundaries for telemedicine 
have thereby been explored (12). During COVID-19 more and 
more dermatologists are being forced to get experience from 
teledermatology, because of the regulations and precautions 
taken during this pandemic. This experience should, in our 
opinion, possibly influence a higher integration of telederma-
tology in our daily clinical practice in the future. Hopefully, 
